EDIT
Editas Medicine
Stock NASDAQ – Stock Market Prices, News & Analysis
Editas Medicine Inc se consacre au développement de thérapies génomiques basées sur la technologie CRISPR pour traiter des maladies génétiques.
$ 2.63
15.17 %
Editas Medicine
$
2.63
15.17 %
EDIT
Editas Medicine Inc se consacre au développement de thérapies génomiques basées sur la technologie CRISPR pour traiter des maladies génétiques.
Price history of Editas Medicine
Price history of Editas Medicine
Performance & Momentum
6 Months
2.93 %
1 Year
68.91 %
3 Years
66.35 %
5 Years
94.31 %
Momentum
79
Similar stocks to Editas Medicine
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
